Scinovex
article Open AccessTop 1% cited

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

New England Journal of Medicine · 1995 · Vol. 333(20) · pp. 1301–1308
James ShepherdStuart M. CobbeIan FordChristopher IslesA R LorimerPeter W. MacfarlaneJames H. McKillopChristopher J. Packard

Abstract

Treatment with pravastatin significantly reduced the incidence of myocardial infarction and death from cardiovascular causes without adversely affecting the risk of death from noncardiovascular causes in men with moderate hypercholesterolemia and no history of myocardial infarction.

Lipoproteins and Cardiovascular HealthStatistical Methods in Clinical TrialsHormonal and reproductive studiesPravastatinMedicineMyocardial infarctionCoronary heart diseaseInternal medicineCardiologyIncidence (geometry)Cholesterol

MeSH terms

Anticholesteremic AgentsCholesterolCoronary DiseaseDouble-Blind MethodHumansHypercholesterolemiaCholesterol, LDLMaleMiddle AgedMyocardial InfarctionNeoplasmsRiskIncidenceSurvival AnalysisPravastatin

Funding

  • Bristol-Myers Squibb
Citations
7,469
FWCI
346.21
field-weighted impact
References
26
Percentile
100%
vs. same field & year
Citations per year
Related articles
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
New England Journal of Medicine · 1995 · 7,469 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.